Production Line Introduction

PHAdustry
Creates Industry 4.0 in the era of biomanufacturing

Beijing, China
Synthetic Biology Flexible Intelligent Manufacturing Line

The synthetic biology flexible intelligent manufacturing line is located in the northern area of Beijing Sino-German Industrial Park, which is the headquarters of PhaBuilder. It was established in October 2022.

Based on the R&D capabilities of the PHAmily series, the intelligent manufacturing line has diverse product manufacturing capabilities, specifically designed for the production of various types of PHA products that meet a variety of differentiated downstream demands, as well as customized high-value medical implant materials.

Multiple Types of PHA

The production line capable of mass-producing the most types of PHA in the world
Transparent Forward and Reverse Fermentation Tank

The world's first, joint mechanical development with Tsinghua University
Digital Operations

Digital Operations

Production Line Introduction

Shanghai, China
R&D Center

The Shanghai R&D Center is located in Zhangjiang, Shanghai, and is PhaBuilder's innovative layout in March 2024. Relying on Shanghai's superior R&D resources and industrial resources, PhaBuilder connects with global industrial partners to jointly develop PHA-based product solutions.

Global Cooperation

Shanghai’s openness has attracted many foreign-funded enterprises and R&D centers, which has helped introduce international advanced technologies and management experience and improved R&D levels.
Complete Industry Chain

The international level of upstream and downstream industrial chain provides abundant cooperation opportunities and application scenarios for the material research and development center
Talent Gathering

Shanghai gathers the regional headquarters or R&D centers of top pharmaceutical companies from around the world, as well as several well-known universities, which provides both talent and technology support for the materials R&D center and is conducive to carrying out high-level scientific research activities.

Production Line Introduction

Yichang, China
Weiqi Biotechnology

In July 2022, PhaBuilder established Weiqi Biotechnology in a joint venture with Angel Biotech, a world-leading yeast company.
The project is located in Hubei Synthetic Biology Industrial Park, with a total investment of RMB 1.05 billion and a total construction area of over 80,000 square meters.

Annual Production of 30,000 Tons

The world's largest NGIB system biomanufacturing plant
Smart Factory

Combining Industry 4.0 technologies to build a biomanufacturing large model
Non-grain Carbon Source

Capable of utilizing non-grain carbon sources for production and manufacturing

Production Line Introduction

China · West
Weining Biotechnology

In January 2024, PhaBuilder established Weining Biotechnology in a joint venture with listed company Chuanning Biotechnology.
Weining Biotechnology will focus on the medical field, develop medical-grade PHA raw materials and related applications, achieve new breakthroughs in PHA in the field of biomedical materials, and promote the integration of PHA into the global biomedical innovation system.

Medical Grade Production Line

Chuanning Biotechnology’s experience in biomedicine + PhaBuilder's synthetic biology technology
BRI Services

Serve Asian and European customers through the Belt and Road Initiative
Integrate PHAdustry

Global leading technology + experience in industrialization of biomanufacturing + advantage resources in bulk materials

Global Layout

PhaBuilder Global Layout

Biomanufacturing + Industry 4.0

Learn about and purchase PhaBuilder PHA

The process digital control rate of the synthetic biology production line reaches 80%
The number of fermentation operators is reduced from the usual 4 to 1
Operation and maintenance efficiency is increased by more than 70%
Simultaneously, more than 10,000 sets of fermentation data were captured using biosensors for precision fermentation.

Precision Fermentation Large Model

Modular Replication
Delivering standardized capabilities to the industry

Building Big Data

Biosensors
10,000+ data modules
Building an Industrial AI Large Model

Modular production
Scaled replication
Industry solutions
Formulate Precision Production Strategies

Production strategy optimization
Precision fermentation

Optimizing Supply
Reduce Costs
Improve Energy Efficiency
Sustainability
Create a Global Benchmark

Production Line Introduction

Beijing, China
Synthetic Biology Flexible Intelligent Manufacturing Line

The synthetic biology flexible intelligent manufacturing line is located in the northern area of Beijing Sino-German Industrial Park, which is the headquarters of PhaBuilder. It was established in October 2022.

Based on the R&D capabilities of the PHAmily series, the intelligent manufacturing line has diverse product manufacturing capabilities, specifically designed for the production of various types of PHA products that meet a variety of differentiated downstream demands, as well as customized high-value medical implant materials.

Multiple Types of PHA

The production line capable of mass-producing the most types of PHA in the world
Transparent Forward and Reverse Fermentation Tank

The world's first, joint mechanical development with Tsinghua University
Digital Operations

Digital Operations

Production Line Introduction

Shanghai, China
R&D Center

The Shanghai R&D Center is located in Zhangjiang, Shanghai, and is PhaBuilder's innovative layout in March 2024. Relying on Shanghai's superior R&D resources and industrial resources, PhaBuilder connects with global industrial partners to jointly develop PHA-based product solutions.

Global Cooperation

Shanghai’s openness has attracted many foreign-funded enterprises and R&D centers, which has helped introduce international advanced technologies and management experience and improved R&D levels.
Complete Industry Chain

The international level of upstream and downstream industrial chain provides abundant cooperation opportunities and application scenarios for the material research and development center
Talent Gathering

Shanghai gathers the regional headquarters or R&D centers of top pharmaceutical companies from around the world, as well as several well-known universities, which provides both talent and technology support for the materials R&D center and is conducive to carrying out high-level scientific research activities.

Production Line Introduction

Yichang, China
Weiqi Biotechnology

In July 2022, PhaBuilder established Weiqi Biotechnology in a joint venture with Angel Biotech, a world-leading yeast company.
The project is located in Hubei Synthetic Biology Industrial Park, with a total investment of RMB 1.05 billion and a total construction area of over 80,000 square meters.

Annual Production of 30,000 Tons

The world's largest NGIB system biomanufacturing plant
Smart Factory

Combining Industry 4.0 technologies to build a biomanufacturing large model
Non-grain Carbon Source

Capable of utilizing non-grain carbon sources for production and manufacturing

Production Line Introduction

China · West
Weining Biotechnology

In January 2024, PhaBuilder established Weining Biotechnology in a joint venture with listed company Chuanning Biotechnology.
Weining Biotechnology will focus on the medical field, develop medical-grade PHA raw materials and related applications, achieve new breakthroughs in PHA in the field of biomedical materials, and promote the integration of PHA into the global biomedical innovation system.

Medical Grade Production Line

Chuanning Biotechnology’s experience in biomedicine + PhaBuilder's synthetic biology technology
BRI Services

Serve Asian and European customers through the Belt and Road Initiative
Integrate PHAdustry

Global leading technology + experience in industrialization of biomanufacturing + advantage resources in bulk materials